
Opinion|Videos|June 24, 2024
Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy
The panel discusses how fusion-guided biopsy can inform patient eligibility for focal therapy in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is the role of fusion-guided biopsy in determining patient eligibility for focal therapy?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Pearls & Perspectives: The Power of Advocacy in Sexual Medicine, With Rachel Rubin, MD
5















